TITLE

On-Demand Therapy for Gastroesophageal Reflux Disease

AUTHOR(S)
Metz, David C.; Inadomi, John M.; Howden, Colin W.; Van Zanten, Sander J. Veldhuyzen; Bytzer, Peter
PUB. DATE
March 2007
SOURCE
American Journal of Gastroenterology;Mar2007, Vol. 102 Issue 3, p642
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The following pages summarize the proceedings of a symposium held in May 2006 on the emerging role of on-demand therapy for gastroesophageal reflux disease (GERD). Medical therapy for GERD has undergone significant change in recent years with the advent of effective, but expensive, antisecretory agents. On-demand (patient-driven) therapy is attractive to payers and patients, because it appears to be both cost-effective and convenient. Many individuals appear to accept occasional symptomatic breakthrough in exchange for personal control of their disease. On-demand therapy should be distinguished from intermittent therapy, which is either patient- or physician-driven, but which requires intermittent episodes of continuous therapy followed by discontinuation until symptoms recur. Proton pump inhibitors appear to be effective on-demand agents despite theoretical pharmacodynamic limitations for this class of drug. The available data support the use of on-demand therapy for GERD in uninvestigated reflux disease, nonerosive reflux disease, and possibly mild esophagitis as well. On-demand therapy should not be considered for patients with severe esophagitis.
ACCESSION #
24165544

 

Related Articles

  • Strategy for treatment of nonerosive reflux disease in Asia. Hiyama, Toru; Yoshihara, Masaharu; Tanaka, Shinji; Haruma, Ken; Chayama, Kazuaki // World Journal of Gastroenterology;5/28/2008, Vol. 14 Issue 20, p3123 

    The paper is to review the clinical and pathophysiologic differences between of nonerosive reflux disease (NERD) and reflux esophagitis (RE), and to propose a treatment strategy for NERD, especially for patients in Asia. A Medline search was performed regarding the clinical and pathophysiologic...

  • Effect of Up to 3 Years of High-dose Lansoprazole on Barrett's Esophagus. Sampliner, R. E. // American Journal of Gastroenterology;Oct1994, Vol. 89 Issue 10, p1844 

    Objective: Barrett's esophagus is a metaplastic condition resulting from gastroesophageal reflux disease. Previous medical and surgical therapies have failed to predictably eradicate Barrett's. The objective of this study was to assess the impact of long-term, high-dose lansoprazole, a proton...

  • Barrett's Esophagus: Symptoms, Diagnosis, and Treatment. Green, Erin E. // Clinical Excellence for Nurse Practitioners;Spring2005, Vol. 9 Issue 1, p7 

    Patients experiencing gastroesophageal reflux on a regular basis may be predisposed to Barrett's esophagus. Barrett's is thought to be a precursor to esophageal cancer. Endoscopy is utilized for both diagnosis and surveillance of this disease. The use of proton pump inhibitors and H2 blockers...

  • I've had heartburn problems. A recent endoscopy showed some inflammation in my esophagus. Now I'm taking a medication for it. How long will I have to take it?  // Mayo Clinic Health Letter;May2011, Vol. 29 Issue 5, p8 

    The article presents questions and answers related to dealing with medication for heartburn.

  • Gastroesophageal Reflux Disease: Endoscopy, Duration of Treatment, and Choice of PPI. Greenspan, Neil R. // Medicine & Health Rhode Island;Apr2011, Vol. 94 Issue 4, p92 

    The article discusses the diagnosis and treatment of gastroesophageal reflux disease (GERD). It offers choices of Proton Pump Inhibitors (PPIs) that have been shown to be more efficacious in controlling acute symptoms and the most effective agents for healing esophagitis. It mentions that...

  • Barrett's Esophagus--What Should I Know About It?  // American Family Physician;5/1/2004, Vol. 69 Issue 9, p2120 

    Provides information on Barrett's esophagus. Disadvantage of too much stomach acid; Association of gastroesophageal reflux disease with Barrett's esophagus; Use of proton pump inhibitors for treating Barrett's esophagus.

  • An empiric approach to GERD-related cough. Mintz, Matthew; Russell, John J. // Patient Care;Jun2003, Vol. 37 Issue 6, p76 

    Discusses a research on the diagnosis and treatment of gastroesophageal reflux disease-related cough. Reference to a study by R. H. Poe and M. C. Kallay, published in a 2003 issue of the journal "Chest"; Assessment of the value of proton-pump inhibitor therapy; Impact of the research findings...

  • Eosinophilic Esophagitis. Bohm, Matthew; Richter, Joel E. // Current Medical Literature: Gastroenterology;2009, Vol. 28 Issue 4, p85 

    The article offers information on the chronic inflammatory disorder of the esophagus called eosinophilic esophagitis (EoE). The disorder's epidemiology, pathogenesis and clinical features are discussed. Treatment options include elimination diets, montelukast, mepolizumab, proton-pump inhibitors...

  • Efficacy of Drugs Used in Gastro-Oesophageal Reflux: Network Meta-Analysis. Bolaños-Díaz, Rafael; Velarde-Criado, Héctor; Cóndor-Mori, Erik // Pharmacology & Pharmacy;Apr2013, Vol. 4 Issue 2, p201 

    Introduction: It is important to rank the clinical efficacy of different anti-reflux agents to promote their rational use. Objective: To combine the results of randomized clinical trials that have compared the incidence of symptoms related to gastro-oesophageal reflux (GER) with/without...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics